We’ve all grown accustomed to the steady parade of television ads—$3 billion year worth, by some estimates—urging us to “ask our doctors” about the latest miracle drug. Pharmaceutical ads have been commonplace since the 1990s, after the U.S. Food & Drug Administration (FDA) cleared the way for prescription drug companies to aggressively market their wares directly to consumers.
Wisdom and ethics aside, it’s easy to see why Big Pharma would push pills to humans, to treat human ailments. It’s big money.
But a drug company that makes animal drugs, purchased not by consumers but by factory farms, advertising direct to consumers who will never actually purchase those drugs? How does that make sense?
If you’re Elanco, the $2.3-billion animal drug division of Eli Lilly, you make it seem sensible by spinning the message. In Elanco’s case, the message is this: Without our animal drugs, the world will starve.
It’s a message that paints the drug maker as an altruistic savior, instead of the profit-motivated animal abuser and public health threat it actually is.